Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Hisashi Oishi"'
Autor:
Yasushi Matsuda, Yamato Suzuki, Sakiko Kumata, Yoshinori Okada, Kazuki Hayasaka, Hisashi Oishi, Masafumi Noda
Publikováno v:
Transplantation Proceedings. 53:1375-1378
Infections caused by the Scedosporium genus have become recognized as a fatal complication after lung transplantation in Europe and Australia, but the reports have been rare from Asian countries including Japan. We present a case of pneumonia caused
Autor:
Hisashi Oishi, Hirotoshi Suzuki, Tatsuaki Watanabe, Mitsuhiro Yamada, Yasushi Matsuda, Yoshinori Okada, Tetsu Sado, Masafumi Noda, Tsutomu Tamada
Publikováno v:
Transplantation Proceedings. 50:2764-2767
Background and Objectives To treat organ transplant patients with mycobacterial infection, physicians need to pay attention to interaction between drugs used against mycobacteria and immunosuppressants. The purpose of this report is to describe the c
Autor:
Yoshinori Okada, S. Maeda, Akira Sakurada, T. Amemiya, Y. Yoshida, Tatsuaki Watanabe, Hideki Mitomo, Hisashi Oishi, Katsuhiko Kamei, Toshiaki Kikuchi, Hirotsugu Notsuda, Yasuhiro H. Matsuda, Tetsu Sado, Hiromichi Niikawa, Masafumi Noda
Publikováno v:
Transplantation Proceedings. 50:939-942
We report a very rare case of pulmonary chromomycosis caused by Scedosporium prolificans that developed after lung transplantation and was successfully treated with endobronchial topical amphotericin B instillation. The subject was a woman in her 50s
Autor:
Yoshinori Okada, Akira Sakurada, Fumihiko Hoshi, Miki Akiba, Yasushi Matsuda, Masafumi Noda, Tetsu Sado, Hiromichi Niikawa, Hisashi Oishi, Tatsuaki Watanabe, S. Eba
Publikováno v:
Transplantation Proceedings. 50:2768-2770
Calcineurin inhibitors are a commonly used immunosuppressive drug and over 80% of lung transplant (LTx) recipients use tacrolimus. Sustained-release tacrolimus (SRT) was developed as a once-daily formulation, resulting in slower release and reduction
Autor:
Yasushi Hoshikawa, Yoshinori Okada, Takashi Kondo, Takeshi Oyaizu, Tetsu Sado, Sei Suzuki, Toshiaki Kikuchi, Hisashi Oishi, Y. Matsumura
Publikováno v:
Transplantation Proceedings. 39:283-285
Background Transferring genes with immunoregulatory capacity to transplanted organs has the potential to modify allograft rejection (AR). We examined the effect of ex vivo lipid-mediated transbronchial human interleukin-10 (hIL-10) gene transfer on a